93 related articles for article (PubMed ID: 28973818)
1. Incremental Costs in Giant Cell Arteritis.
Mounié M; Costa N; Sailler L; Lapeyre-Mestre M; Bourrel R; Savy N; Molinier L; Pugnet G
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):1074-1081. PubMed ID: 28973818
[TBL] [Abstract][Full Text] [Related]
2. Additional Costs of Polymyalgia Rheumatica With Giant Cell Arteritis.
Mounié M; Pugnet G; Savy N; Lapeyre-Mestre M; Molinier L; Costa N
Arthritis Care Res (Hoboken); 2019 Aug; 71(8):1127-1131. PubMed ID: 30156754
[TBL] [Abstract][Full Text] [Related]
3. Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
Koster MJ; Achenbach SJ; Crowson CS; Maradit-Kremers H; Matteson EL; Warrington KJ
J Rheumatol; 2017 Jul; 44(7):1044-1050. PubMed ID: 28461641
[TBL] [Abstract][Full Text] [Related]
4. Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001-2017).
Valent F; Bond M; Cavallaro E; Treppo E; Rosalia Maria DR; Tullio A; Dejaco C; De Vita S; Quartuccio L
Vasc Med; 2020 Apr; 25(2):150-156. PubMed ID: 31804152
[TBL] [Abstract][Full Text] [Related]
5. Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.
Michet CJ; Achenbach SJ; Crowson CS; Matteson EL
Semin Arthritis Rheum; 2015 Aug; 45(1):70-4. PubMed ID: 25824865
[TBL] [Abstract][Full Text] [Related]
6. Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study.
Pugnet G; Sailler L; Bourrel R; Montastruc JL; Lapeyre-Mestre M
J Rheumatol; 2015 Feb; 42(2):316-22. PubMed ID: 25512477
[TBL] [Abstract][Full Text] [Related]
7. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study.
Pugnet G; Sailler L; Fournier JP; Bourrel R; Montastruc JL; Lapeyre-Mestre M
J Rheumatol; 2016 Dec; 43(12):2162-2170. PubMed ID: 27585686
[TBL] [Abstract][Full Text] [Related]
9. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
Petri H; Nevitt A; Sarsour K; Napalkov P; Collinson N
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):390-5. PubMed ID: 25132663
[TBL] [Abstract][Full Text] [Related]
10. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.
Ninan J; Nguyen AM; Cole A; Rischmueller M; Dodd T; Roberts-Thomson P; Hill CL
J Rheumatol; 2011 Oct; 38(10):2215-7. PubMed ID: 21844141
[TBL] [Abstract][Full Text] [Related]
11. Mortality among Patients with Giant Cell Arteritis: A Large-scale Population-based Cohort Study.
Ben-Shabat N; Tiosano S; Shovman O; Comaneshter D; Shoenfeld Y; Cohen AD; Amital H
J Rheumatol; 2020 Sep; 47(9):1385-1391. PubMed ID: 31839591
[TBL] [Abstract][Full Text] [Related]
12. Estimating the Cost of Illness of Giant Cell Arteritis in the United States.
Babigumira JB; Li M; Boudreau DM; Best JH; Garrison LP
Rheumatol Ther; 2017 Jun; 4(1):111-119. PubMed ID: 28084585
[TBL] [Abstract][Full Text] [Related]
13. Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.
Unizony S; Lu N; Tomasson G; Zhang Y; Merkel PA; Stone JH; Antonio Aviña-Zubieta J; Choi HK
Arthritis Rheumatol; 2017 Jan; 69(1):176-184. PubMed ID: 28029234
[TBL] [Abstract][Full Text] [Related]
14. Projected worldwide disease burden from giant cell arteritis by 2050.
De Smit E; Palmer AJ; Hewitt AW
J Rheumatol; 2015 Jan; 42(1):119-25. PubMed ID: 25362658
[TBL] [Abstract][Full Text] [Related]
15. Incidence of infections in patients with giant cell arteritis: a cohort study.
Durand M; Thomas SL
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):581-8. PubMed ID: 22184094
[TBL] [Abstract][Full Text] [Related]
16. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
17. Malignancy risk in patients with giant cell arteritis: a population-based cohort study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):149-54. PubMed ID: 20191512
[TBL] [Abstract][Full Text] [Related]
18. Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
Faurschou M; Ahlström MG; Lindhardsen J; Obel N; Baslund B
J Rheumatol; 2017 Jan; 44(1):78-83. PubMed ID: 27744394
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study.
Muratore F; Cavazza A; Boiardi L; Lo Gullo A; Pipitone N; Germanò G; Bisagni A; Cimino L; Salvarani C
Arthritis Care Res (Hoboken); 2016 Jun; 68(6):865-70. PubMed ID: 26415044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
